本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Amphastar Pharmaceuticals

24.50
+0.62002.60%
盘后24.500.00000.00%18:57 EDT
成交量:67.41万
成交额:1,648.40万
市值:11.64亿
市盈率:8.01
高:24.69
开:24.41
低:24.19
收:23.88
数据加载中...
2024/06/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

重要事件披露

Form 8-K - Current report
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities